Subarachnoid hemorrhage (SAH) associated with a ruptured cerebral aneurysm remains a source of significant morbidity and mortality, not only from the initial hemorrhage but also from the delayed complications, such as cerebral vasospasm often severe enough to induce irreversible changes in cerebral perfusion. Several drugs have been developed that have the potential to limit cerebral vasospasm and delayed ischemic neurologic deficit, thus improving outcome for patients.

Grasso, G., Tomasello, F. (2012). Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?. WORLD NEUROSURGERY, 77(1), 46-48 [10.1016/j.wneu.2011.01.028].

Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?

GRASSO, Giovanni;
2012-01-01

Abstract

Subarachnoid hemorrhage (SAH) associated with a ruptured cerebral aneurysm remains a source of significant morbidity and mortality, not only from the initial hemorrhage but also from the delayed complications, such as cerebral vasospasm often severe enough to induce irreversible changes in cerebral perfusion. Several drugs have been developed that have the potential to limit cerebral vasospasm and delayed ischemic neurologic deficit, thus improving outcome for patients.
Settore MED/27 - Neurochirurgia
Grasso, G., Tomasello, F. (2012). Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?. WORLD NEUROSURGERY, 77(1), 46-48 [10.1016/j.wneu.2011.01.028].
File in questo prodotto:
File Dimensione Formato  
Erythropoietin for subarachnoid.pdf

Solo gestori archvio

Dimensione 1.96 MB
Formato Adobe PDF
1.96 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/88448
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 8
social impact